EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

UTI Inc (179900) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of UTI Inc KRW 2,031, price KRW 2,315, upside -12.3%, quality 12 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Technology · KR · ISIN KR7179900006

UI Thin data Sep 24, 2026

UTI Inc

179900 · KQ

Weak valuationQuality is weak on top of the rich price.

!Fair value 2,031 KRW · Overvalued (−12%)
!Quality 12/100
!Weak Growth (revenue 5y −19.6 %/yr)
!Loss-making · -187.2% net margin (FY2025)
!Low debt · negative free cash flow
!Trails peers (1/7)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 17 out of 100
!Weak on future: 7 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

42,050 KRW 1,819 KRW Fair Value 2,031 KRW May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 1,819 KRW – 42,050 KRW · fair‑value band 1,516 KRW – 3,032 KRW · the 2,315 KRW price screens above the 2,031 KRW fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow UTI in your weekly email

Every Wednesday you see whether UTI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

UTI Inc. engages in the research, development, manufacture, and sale of smartphone camera windows and sensor glasses in South Korea and internationally.

Show more

UTI Inc. engages in the research, development, manufacture, and sale of smartphone camera windows and sensor glasses in South Korea and internationally. The company offers cover glass for recognizing fingerprints, glass for IOT, 3D cover glass, flexible display cover glass, G2 TSP and AG glass for car industry; and IOT/ICT composite sensor module, smart haptic module, motor for low-powered drone, and interposer and spacer for semi-conductor industry. The company was founded in 2010 and is headquartered in Yesan-Eup, South Korea.

Stock analysis

UTI Inc (179900) currently trades at 2,315 KRW, while our model-based Fair Value estimate is 2,031 KRW, implying the stock looks roughly 14.0% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 1,516 KRW (bear) to 3,032 KRW (bull), the price of 2,315 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 12/100 (below-average quality), in the Technology sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

UTI Inc reported revenue of 20.0B KRW in FY2025 versus 45.2B KRW in FY2021, a compound −18.5%/yr. Reported net income was −37.4B KRW in FY2025.

Key figures

Market cap 54.7B KRW (≈ $40.2M) · P/S ratio 2.73 · Net margin −208% · Return on equity −68.0% · Return on assets (EBIT) −14.0% · Operating margin −276% · Revenue (TTM) 20.0B KRW · Revenue growth (YoY) +1.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 92% below its 52-week high and 27% above its 52-week low.

For context, the median of 10 Technology peers we cover trades at −66% fair-value upside, at −12%, 179900 screens cheaper than that median.

Fair Value models

Bear 1,516 KRW Fair Value 2,031 KRW Bull 3,032 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Gordon GGM 0.2800 KRW 0.3100 KRW 0.3500 KRW 69
DDM Multi-Stage 0.2800 KRW 0.3500 KRW 0.4400 KRW 67
NCAV (Graham) 1,671 KRW 2,239 KRW 3,341 KRW 54
All 3 models by family
Dividend Discount
Gordon GGM 0.2800 KRW 0.3100 KRW 0.3500 KRW 69
DDM Multi-Stage 0.2800 KRW 0.3500 KRW 0.4400 KRW 67
Asset-Based
NCAV (Graham) 1,671 KRW 2,239 KRW 3,341 KRW 54

Open the full fair value analysis →

Notify me when 179900 reaches fair value

Put 179900 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 12/100

Of which business quality 16 · Market factors (momentum, volatility) 6

Profitability 0
Margins and returns on capital today
Quality Growth 25
Are margins and returns improving?
Cashflow 10
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 14
Disciplined investing over empire-building
Low Volatility 18
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 7
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−19.6%
Start year 2020 (pandemic). Over 10 years: +2.7% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.3% (2020) → −241.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

179900 screens 14% overvalued. Compare with Amphenol Corporation →

Compare UTI Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 654 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 12 · Bottom 25%
Fair Value upside −12% · Above median
Profitability
Return on assets −17% · Bottom 25%
Net margin (TTM) −187% · Bottom 25%
Growth and dividend
Revenue growth 1% · Below median
Balance sheet
Debt / equity 0.34× · Highest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)17 · sector 0
FUTURE (revenue growth)7 · sector 38
PAST (return on equity)0 · sector 26
HEALTH (low debt)83 · sector 95
DIVIDEND (yield)0 · sector 25

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Electronic Components stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Amphenol Corporation APH $83.08 $84.44 +2%
Delta Electronics, Inc 2308 1,910 TWD 519.57 TWD −73%
Corning Incorporated GLW $154.15 $33.52 −78%
Hon Hai Precision Industry Co 2317 250.50 TWD 293.80 TWD +17%
Samsung Electro-Mechanics Co 009150 1,507,000 KRW 171,572 KRW −89%
Luxshare Precision Industry Co 002475 ¥54.84 ¥18.55 −66%
Suzhou Dongshan Precision Manufacturing Co 002384 ¥198.12 ¥21.19 −89%
TE Connectivity plc TEL $213.48 $140.75 −34%
Elite Material Co 2383 5,050 TWD 800.51 TWD −84%
Yageo Corporation 2327 580.00 TWD 527.64 TWD −9%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "UTI Inc Fair Value". https://www.fairvalue-calculator.com/stock/179900

Frequently asked questions

Is UTI Inc (179900) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 2,031 KRW versus a price of 2,315 KRW, about −12% upside (overvalued).
What is the fair value of 179900?
Our model-based fair value for UTI Inc is 2,031 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,315 KRW.
What is the quality score of 179900?
UTI Inc has a Quality Score of 12/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UTI Inc (179900)?
Our model-based price target is the fair value of 2,031 KRW (as of Sep 24, 2026) from 3 valuation models. Cautious scenario 1,516 KRW, optimistic scenario 3,032 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the UTI Inc stock forecast for 2026?
Our models put fair value at 2,031 KRW, about −12% upside versus a price of 2,315 KRW (overvalued). Cautious scenario 1,516 KRW, optimistic scenario 3,032 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of UTI Inc (179900)?
UTI Inc reported trailing-twelve-month revenue of about 20.0B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of UTI Inc (179900)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UTI Inc it is 2,031 KRW per share (as of Sep 24, 2026), against a price of 2,315 KRW. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is UTI Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 179900 trades above its calculated fair value: price 2,315 KRW, fair value 2,031 KRW, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 179900?
No. The price is what the market pays today (2,315 KRW); the fair value is what the company's own numbers justify (2,031 KRW). For UTI Inc the two are 283.63 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is UTI Inc worth?
The market values UTI Inc at about 54.7B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 2,315 KRW; our models calculate a fair value of 2,031 KRW per share.
What do the bullish and bearish scenarios say about 179900?
Our models span a range for UTI Inc: cautious scenario 1,516 KRW, base 2,031 KRW, optimistic 3,032 KRW per share (as of Sep 24, 2026, price 2,315 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of UTI Inc (179900)?
Balance-sheet figures for UTI Inc (as of Sep 24, 2026): return on equity −68.0%, debt of 0.34 per unit of equity. They feed the Quality Score of 12/100, which measures business quality independently of the share price.
How far is 179900 from its 52-week high?
UTI Inc trades at 2,315 KRW, about 92% below its 52-week high of 28,250 KRW and 27% above the low of 1,819 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 2,031 KRW is for.
Which stocks are comparable to UTI Inc?
From the same area (Technology) we also value Amphenol Corporation, Delta Electronics, Inc, Corning Incorporated, Hon Hai Precision Industry Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UTI Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 2,315 KRW, calculated fair value 2,031 KRW (−12%), Quality Score 12/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 179900 calculated?
We run UTI Inc through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,031 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. UTI Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UTI Inc (179900)?
The closing price on Sep 23, 2026 was 2,315 KRW. Our model-based fair value is 2,031 KRW, about −12% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UTI Inc right now?
A fairly wide model range (1,516 KRW to 3,032 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of UTI Inc

How large is the market capitalisation of UTI Inc (179900)?
The market capitalisation of UTI Inc is 54.7B KRW (≈ $40.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UTI Inc (179900)?
The price-to-sales ratio of UTI Inc is 2.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of UTI Inc (179900)?
The net margin of UTI Inc is −208% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UTI Inc (179900)?
The return on equity (ROE) of UTI Inc is −68.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UTI Inc (179900)?
On an EBIT basis the return on assets of UTI Inc is −14.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UTI Inc (179900)?
The operating margin of UTI Inc is −276% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UTI Inc (179900)?
Revenue at UTI Inc is growing +1.4% versus a year earlier (3y avg −18.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UTI Inc (179900)?
Earnings per share at UTI Inc are growing +41.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does UTI Inc (179900) generate?
The free cash flow of UTI Inc is −110B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does UTI Inc (179900) carry?
The net debt of UTI Inc is 12.2B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch UTI Inc in the live analysis

One click puts UTI Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.